SOD1 and amyotrophic lateral sclerosis: Based on previous evidence that CuATSM, ebselen and telbivudine reduce SOD1 toxicity, we aimed to establish whether a combination of CuATSM, ebselen and telbivudine would be more effective than CuATSM in protecting against SOD1-associated ALS pathology.